Cargando…

A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma

OBJECTIVES: The postoperative early recurrence (ER) rate of hepatocellular carcinoma (HCC) is 50%, and no highly reliable predictive tool has been developed yet. The aim of this study was to develop and validate a predictive model with radiomics analysis based on multiparametric magnetic resonance (...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wencui, Shen, Hongru, Han, Lizhu, Liu, Jiaxin, Xiao, Bohan, Li, Xubin, Ye, Zhaoxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534653/
https://www.ncbi.nlm.nih.gov/pubmed/36213823
http://dx.doi.org/10.1155/2022/3704987
_version_ 1784802591664766976
author Li, Wencui
Shen, Hongru
Han, Lizhu
Liu, Jiaxin
Xiao, Bohan
Li, Xubin
Ye, Zhaoxiang
author_facet Li, Wencui
Shen, Hongru
Han, Lizhu
Liu, Jiaxin
Xiao, Bohan
Li, Xubin
Ye, Zhaoxiang
author_sort Li, Wencui
collection PubMed
description OBJECTIVES: The postoperative early recurrence (ER) rate of hepatocellular carcinoma (HCC) is 50%, and no highly reliable predictive tool has been developed yet. The aim of this study was to develop and validate a predictive model with radiomics analysis based on multiparametric magnetic resonance (MR) images to predict early recurrence of HCC. METHODS: In total, 302 patients (training dataset: n = 211; validation dataset: n = 91) with pathologically confirmed HCC who underwent preoperative MR imaging were enrolled in this study. Three-dimensional regions of interest of the entire lesion were accessed by manually drawing along the tumor margins on the multiple sequences of MR images. Least absolute shrinkage and selection operator Cox regression were then applied to select ER-related radiomics features and construct radiomics signatures. Univariate analysis and multivariate Cox regression analysis were used to identify the significant clinico-radiological factors and establish a clinico-radiological model. A predictive model of ER incorporating the fusion radiomics signature and clinico-radiological risk factors was constructed. The diagnostic performance and clinical utility of this model were measured by receiver-operating characteristic (ROC), calibration curve, and decision curve analyses. RESULTS: The fusion radiomics signature consisting of 6 radiomics features achieved good prediction performance (training dataset: AUC = 0.85, validation dataset: AUC = 0.79). The predictive model of ER integrating clinico-radiological risk factors and the fusion radiomics signature improved the prediction efficacy with AUCs of 0.91 and 0.87 in the training and validation datasets, respectively. Furthermore, the nomogram and ER risk stratification system based on the predictive model demonstrated encouraging predictions of the individualized risk of ER and gave three risk groups with low, intermediate, or high risk of ER. CONCLUSIONS: The proposed predictive model incorporating clinico-radiological factors and the fusion radiomics signature derived from multiparametric MR images may be an effective tool for the individualized prediction of postoperative ER in patients with HCC.
format Online
Article
Text
id pubmed-9534653
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95346532022-10-06 A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma Li, Wencui Shen, Hongru Han, Lizhu Liu, Jiaxin Xiao, Bohan Li, Xubin Ye, Zhaoxiang J Oncol Research Article OBJECTIVES: The postoperative early recurrence (ER) rate of hepatocellular carcinoma (HCC) is 50%, and no highly reliable predictive tool has been developed yet. The aim of this study was to develop and validate a predictive model with radiomics analysis based on multiparametric magnetic resonance (MR) images to predict early recurrence of HCC. METHODS: In total, 302 patients (training dataset: n = 211; validation dataset: n = 91) with pathologically confirmed HCC who underwent preoperative MR imaging were enrolled in this study. Three-dimensional regions of interest of the entire lesion were accessed by manually drawing along the tumor margins on the multiple sequences of MR images. Least absolute shrinkage and selection operator Cox regression were then applied to select ER-related radiomics features and construct radiomics signatures. Univariate analysis and multivariate Cox regression analysis were used to identify the significant clinico-radiological factors and establish a clinico-radiological model. A predictive model of ER incorporating the fusion radiomics signature and clinico-radiological risk factors was constructed. The diagnostic performance and clinical utility of this model were measured by receiver-operating characteristic (ROC), calibration curve, and decision curve analyses. RESULTS: The fusion radiomics signature consisting of 6 radiomics features achieved good prediction performance (training dataset: AUC = 0.85, validation dataset: AUC = 0.79). The predictive model of ER integrating clinico-radiological risk factors and the fusion radiomics signature improved the prediction efficacy with AUCs of 0.91 and 0.87 in the training and validation datasets, respectively. Furthermore, the nomogram and ER risk stratification system based on the predictive model demonstrated encouraging predictions of the individualized risk of ER and gave three risk groups with low, intermediate, or high risk of ER. CONCLUSIONS: The proposed predictive model incorporating clinico-radiological factors and the fusion radiomics signature derived from multiparametric MR images may be an effective tool for the individualized prediction of postoperative ER in patients with HCC. Hindawi 2022-09-28 /pmc/articles/PMC9534653/ /pubmed/36213823 http://dx.doi.org/10.1155/2022/3704987 Text en Copyright © 2022 Wencui Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Wencui
Shen, Hongru
Han, Lizhu
Liu, Jiaxin
Xiao, Bohan
Li, Xubin
Ye, Zhaoxiang
A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma
title A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma
title_full A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma
title_fullStr A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma
title_full_unstemmed A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma
title_short A Multiparametric Fusion Radiomics Signature Based on Contrast-Enhanced MRI for Predicting Early Recurrence of Hepatocellular Carcinoma
title_sort multiparametric fusion radiomics signature based on contrast-enhanced mri for predicting early recurrence of hepatocellular carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534653/
https://www.ncbi.nlm.nih.gov/pubmed/36213823
http://dx.doi.org/10.1155/2022/3704987
work_keys_str_mv AT liwencui amultiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT shenhongru amultiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT hanlizhu amultiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT liujiaxin amultiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT xiaobohan amultiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT lixubin amultiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT yezhaoxiang amultiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT liwencui multiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT shenhongru multiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT hanlizhu multiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT liujiaxin multiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT xiaobohan multiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT lixubin multiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma
AT yezhaoxiang multiparametricfusionradiomicssignaturebasedoncontrastenhancedmriforpredictingearlyrecurrenceofhepatocellularcarcinoma